Journal article
Acute IL-4 Governs Pathogenic T Cell Responses during Leishmania major Infection
ImmunoHorizons, Vol.4(9), pp.546-560
09/18/2020
DOI: 10.4049/immunohorizons.2000076
PMCID: PMC7640617
PMID: 32948646
Abstract
spp. infection is a global health problem affecting more than 2 million people every year with 300 million at risk worldwide. It is well established that a dominant Th1 response (IFN-γ, a hallmark Th1 cytokine) provides resistance, whereas a dominant Th2 response (IL-4, a hallmark Th2 cytokine) confers susceptibility during infection. Given the important role of IL-4 during
infection, we used IL-4-neutralizing Abs to investigate the cellular and molecular events regulated by IL-4 signaling. As previously published, neutralization of IL-4 in
-infected BALB/c mice (a
susceptible strain) provided protection when compared with control
-infected BALB/c mice. Despite this protection, IFN-γ production by T cells was dramatically reduced. Temporal neutralization of IL-4 revealed that acute IL-4 produced within the first days of infection is critical for not only programming IL-4-producing Th2 CD4
T cells, but for promoting IFN-γ produced by CD8
T cells. Mechanistically, IL-4 signaling enhances anti-CD3-induced Tbet and IFN-γ expression in both CD4
and CD8
T cells. Given the pathogenic role of IFN-γ-producing CD8
T cells, our data suggest that IL-4 promotes cutaneous leishmaniasis pathology by not only promoting Th2 immune responses but also pathogenic CD8
T cell responses. Our studies open new research grounds to investigate the unsuspected role of IL-4 in regulating both Th1 and Th2 responses.
Details
- Title: Subtitle
- Acute IL-4 Governs Pathogenic T Cell Responses during Leishmania major Infection
- Creators
- Barun Poudel - University of IowaMatthew S Yorek - University of IowaLalita Mazgaeen - University of IowaScott A Brown - St. Jude Children's Research HospitalThirumala-Devi Kanneganti - St. Jude Children's Research HospitalPrajwal Gurung - University of Iowa
- Resource Type
- Journal article
- Publication Details
- ImmunoHorizons, Vol.4(9), pp.546-560
- DOI
- 10.4049/immunohorizons.2000076
- PMID
- 32948646
- PMCID
- PMC7640617
- NLM abbreviation
- Immunohorizons
- ISSN
- 2573-7732
- eISSN
- 2573-7732
- Grant note
- R01 AI101935 / NIAID NIH HHS R01 AR056296 / NIAMS NIH HHS R37 AI101935 / NIAID NIH HHS R21 AI148904 / NIAID NIH HHS R01 CA163507 / NCI NIH HHS R01 AI124346 / NIAID NIH HHS
- Language
- English
- Date published
- 09/18/2020
- Academic Unit
- Infectious Diseases; Stead Family Department of Pediatrics; Pathology; Internal Medicine
- Record Identifier
- 9984360046002771
Metrics
18 Record Views